drugset / Trial / NCT00452270

Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

NCT00452270

Phase 3 Completed 60 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to characterize the time profile of the decongestant properties of xylometazoline and to investigate its effect on sleep, general well-being and smell/taste.

Timeline

Start
2007-03
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Xylometazoline Small molecule

Indications